Current Atherosclerosis Reports
Scope & Guideline
Empowering clinicians with cutting-edge findings.
Introduction
Aims and Scopes
- Atherosclerosis Mechanisms and Pathophysiology:
Research exploring the underlying biological and molecular mechanisms of atherosclerosis, including inflammation, lipid metabolism, and vascular biology. - Clinical Management and Therapeutics:
Focused studies on various treatment modalities for atherosclerosis, including pharmacotherapy, lifestyle interventions, and novel therapeutic approaches such as gene editing and monoclonal antibodies. - Epidemiology and Risk Factors:
Investigations into the epidemiology of cardiovascular diseases, identifying risk factors such as genetics, lifestyle, and social determinants of health. - Pediatric and Adolescent Cardiovascular Health:
Research dedicated to understanding and managing cardiovascular risks in younger populations, including familial hypercholesterolemia and dyslipidemia. - Emerging Technologies in Cardiovascular Research:
Utilization of advanced technologies such as artificial intelligence, machine learning, and digital health innovations to enhance cardiovascular disease prevention and management. - Nutritional and Behavioral Interventions:
Studies that examine the impact of diet, nutrition, and behavioral changes on cardiovascular health, emphasizing the importance of community-based approaches.
Trending and Emerging
- Digital Health and Artificial Intelligence:
Recent publications emphasize the integration of digital health technologies and artificial intelligence in cardiovascular disease prevention and management, reflecting a modern approach to patient care. - Social Determinants of Health:
An increasing number of studies address the impact of social determinants on cardiovascular health, underscoring the need for equitable healthcare solutions and community interventions. - Personalized Medicine and Genomics:
Emerging themes in personalized medicine, including the application of genetic testing and polygenic risk scores, are gaining traction as researchers seek to tailor treatments based on individual risk profiles. - Gut Microbiome and Cardiovascular Disease:
There is a growing interest in the relationship between the gut microbiome and cardiovascular health, exploring how microbial factors may influence atherosclerosis and metabolic disorders. - Mental Health and Cardiovascular Outcomes:
Research linking mental health conditions, such as depression and anxiety, with cardiovascular disease risk is becoming more prevalent, highlighting the importance of holistic approaches to patient care.
Declining or Waning
- Traditional Lipid Management Strategies:
There is a noticeable decrease in papers focusing solely on traditional lipid management strategies, such as statins, as newer therapies and comprehensive approaches gain importance. - Basic Science Studies without Clinical Relevance:
Research that lacks direct clinical applications or relevance to patient care is becoming less frequent, signaling a shift towards studies that bridge laboratory findings with real-world outcomes. - Single Risk Factor Studies:
Research concentrating on isolated cardiovascular risk factors is declining, with a growing emphasis on multifactorial approaches that consider the complex interplay of various risk elements. - Purely Genetic Studies:
While genetics remains a vital area of research, there is a waning interest in studies that do not integrate genetic findings with clinical implications or broader epidemiological perspectives.
Similar Journals
CIRCULATION
Unveiling Breakthroughs in Cardiovascular Science.CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.
CIRCULATION RESEARCH
Leading the way in cardiovascular research since 1953.CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.
CURRENT OPINION IN LIPIDOLOGY
Exploring the forefront of lipid science.Current Opinion in Lipidology is a premier journal published by Lippincott Williams & Wilkins, offering critical insights into the ever-evolving landscape of lipid research. With an impressive convergence spanning from 1990 to 2024, this journal serves as an essential platform for researchers, clinicians, and professionals dedicated to the study of lipids in relation to cardiovascular health, endocrinology, and metabolism. The journal currently holds a distinguished Q1 ranking in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, showcasing its significant impact in these fields. Additionally, it ranks in the Q2 quartile for Cell Biology and Molecular Biology, underlining its comprehensive approach to lipidology. Though not open access, the content is rich with cutting-edge reviews, clinical studies, and expert opinions that aim to advance knowledge and practice in lipid metabolism, making it a valuable resource for anyone seeking to stay abreast of the latest developments in lipid research.
Cardiology Journal
Empowering global research in cardiology.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
International Journal of Cardiology Cardiovascular Risk and Prevention
Unlocking the Future of Cardiology ResearchInternational Journal of Cardiology Cardiovascular Risk and Prevention is a distinguished Open Access journal published by ELSEVIER, dedicated to advancing research in the realms of cardiology and cardiovascular medicine. With an ISSN of 2772-4875 and based in the Netherlands, this journal has rapidly established itself as a critical resource for academics and practitioners since its inception in 2021. The journal currently holds a respectable impact factor and occupies the Q2 quartile in both Cardiology and Cardiovascular Medicine and Internal Medicine categories, reflecting its commitment to sharing high-quality research. Researchers can take advantage of its open-access model, ensuring that cutting-edge findings are freely available to a global audience. The journal not only covers innovative studies on cardiovascular risk factors and prevention strategies but also aims to facilitate interdisciplinary collaboration. With an ongoing trajectory from 2021 to 2024, the International Journal of Cardiology Cardiovascular Risk and Prevention is poised to remain a pivotal platform for dialogue and discovery in the evolving landscape of cardiovascular health.
JACC-Basic to Translational Science
Exploring the Frontiers of Cardiovascular InnovationJACC-Basic to Translational Science, published by Elsevier Science Inc, is a distinguished open access journal that has been advancing the field of cardiology and cardiovascular medicine since its inception in 2016. With an ISSN of 2452-302X and an impressive Q1 ranking in Cardiology and Cardiovascular Medicine as per the 2023 category quartiles, the journal is recognized for its commitment to publishing high-quality research that bridges the gap between basic science and clinical application. Operating from its base in the United States, JACC-Basic to Translational Science is at the forefront of enriching the academic community and healthcare professionals with cutting-edge studies and insights. The journal's robust reach is highlighted by its rank of #14 out of 387 in Scopus for its pertinent subject area, placing it in the 96th percentile. It aims to provide an open access platform that fosters collaboration and the exchange of ideas to ensure the continuous advancement of cardiovascular research. Readers can easily access the latest findings and contribute to the ever-evolving landscape of cardiology through this esteemed publication.
Anatolian Journal of Cardiology
Connecting Global Hearts with Cutting-edge Cardiovascular Knowledge.The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.
CIRCULATION JOURNAL
Advancing Cardiovascular Knowledge, One Study at a Time.CIRCULATION JOURNAL, published by the Japanese Circulation Society, stands as a premier platform for cutting-edge research in the fields of Cardiology and Cardiovascular Medicine. With an impressive impact factor placing it in the Q1 quartile for both cardiology and general medicine, this journal is essential for researchers and practitioners seeking to stay at the forefront of cardiovascular science. The journal's accessible open access options ensure that groundbreaking studies are widely disseminated, reflecting its commitment to advancing medical knowledge and improving patient care. Since its inception in 1996, CIRCULATION JOURNAL has fostered a global dialogue on vital cardiovascular issues, making it a vital resource for academics, healthcare professionals, and students alike. With its base in Tokyo, Japan, the journal not only highlights regional advancements but also contributes significantly to the global medical community.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Exploring the frontiers of cardiovascular medicine and innovation.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.
Acta Cardiologica Sinica
Championing Excellence in Cardiovascular Research.Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.